ASC-话题@MedSci

#ASC#

1352篇内容 | 3992人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939392, encodeId=da11193939294, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO：Denosumab辅助治疗乳腺癌的长期预后, objectType=article, longId=728244, objectId=9c3ce282447f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c3ce282447f, replyNumber=0, likeNumber=76, createdTime=2022-11-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c3ce282447f, moduleTitle=ASCO：Denosumab辅助治疗乳腺癌的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c3ce282447f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939254, encodeId=4a33193925475, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Res：Kcnk3 功能障碍促进左心疾病相关肺动脉高压进展, objectType=article, longId=218217, objectId=501c21821ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=501c21821ed9, replyNumber=0, likeNumber=70, createdTime=2022-04-28, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=501c21821ed9, moduleTitle=Cardiovasc Res：Kcnk3 功能障碍促进左心疾病相关肺动脉高压进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=501c21821ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939403, encodeId=67371939403de, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 新辅助化疗对Borrmann Ⅳ型胃癌疗效有限, objectType=article, longId=728530, objectId=7500e285305a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7500e285305a, replyNumber=0, likeNumber=95, createdTime=2022-07-12, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7500e285305a, moduleTitle=ASCO 2022 | 新辅助化疗对Borrmann Ⅳ型胃癌疗效有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7500e285305a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939257, encodeId=205b193925eb4, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：空腹血糖变异性越高，心血管疾病风险越高！, objectType=article, longId=218766, objectId=ca62218e6648, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca62218e6648, replyNumber=0, likeNumber=85, createdTime=2022-03-26, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca62218e6648, moduleTitle=Cardiovasc Diabetol：空腹血糖变异性越高，心血管疾病风险越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca62218e6648)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939389, encodeId=01961939389b9, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：基于查尔森合并症指数（CCI）预测急性早幼粒细胞白血病（APL）的早期死亡率和总生存期, objectType=article, longId=728460, objectId=e715e2846054, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e715e2846054, replyNumber=0, likeNumber=77, createdTime=2022-11-22, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e715e2846054, moduleTitle=2022 ASCO：基于查尔森合并症指数（CCI）预测急性早幼粒细胞白血病（APL）的早期死亡率和总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e715e2846054)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939309, encodeId=88731939309b8, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=CARDIOVASC DIABETOL：在有心血管高风险因素的糖尿病患者中，运动频率与肾脏、心血管转归的关系如何？, objectType=article, longId=294886, objectId=b831294886b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b831294886b9, replyNumber=0, likeNumber=80, createdTime=2022-07-22, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b831294886b9, moduleTitle=CARDIOVASC DIABETOL：在有心血管高风险因素的糖尿病患者中，运动频率与肾脏、心血管转归的关系如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b831294886b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939281, encodeId=d8731939281ea, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：血脂变异性对2型糖尿病患者死亡率的影响, objectType=article, longId=221157, objectId=d12922115e10, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12922115e10, replyNumber=0, likeNumber=86, createdTime=2022-01-10, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12922115e10, moduleTitle=Cardiovasc Diabetol：血脂变异性对2型糖尿病患者死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d12922115e10)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939432, encodeId=5267193943219, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | MAINTAIN全新思路：CDK4/6抑制剂失败后跨线再战，瑞博西利仍可带来PFS获益！, objectType=article, longId=729096, objectId=317ae2909688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=317ae2909688, replyNumber=0, likeNumber=0, createdTime=2022-11-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=317ae2909688, moduleTitle=ASCO 2022 | MAINTAIN全新思路：CDK4/6抑制剂失败后跨线再战，瑞博西利仍可带来PFS获益！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=317ae2909688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939424, encodeId=fb401939424be, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, objectType=article, longId=728833, objectId=026ae2883362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=026ae2883362, replyNumber=0, likeNumber=71, createdTime=2023-02-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=026ae2883362, moduleTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=026ae2883362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939335, encodeId=85d4193933528, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果, objectType=article, longId=302023, objectId=f6e5302023a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e5302023a2, replyNumber=0, likeNumber=68, createdTime=2022-11-07, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e5302023a2, moduleTitle=BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e5302023a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939324, encodeId=7a0619393244b, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：内脏肥胖指数越高，糖尿病肾病风险越高！, objectType=article, longId=300099, objectId=25f0300099ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25f0300099ca, replyNumber=0, likeNumber=87, createdTime=2022-06-26, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25f0300099ca, moduleTitle=Cardiovasc Diabetol：内脏肥胖指数越高，糖尿病肾病风险越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25f0300099ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939478, encodeId=dcb319394e8cd, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=肿瘤患者治疗期间如何饮食、运动、体重管理？ASCO指南来指导, objectType=article, longId=733690, objectId=057ee3369052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=057ee3369052, replyNumber=0, likeNumber=67, createdTime=2022-09-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=057ee3369052, moduleTitle=肿瘤患者治疗期间如何饮食、运动、体重管理？ASCO指南来指导, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=057ee3369052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939321, encodeId=cef1193932155, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Journal of Vascular Surgery：重磅｜慢性肠系膜缺血：血管外科学会临床实践指南, objectType=article, longId=299858, objectId=c5ac299858ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5ac299858ae, replyNumber=0, likeNumber=84, createdTime=2022-11-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5ac299858ae, moduleTitle=Journal of Vascular Surgery：重磅｜慢性肠系膜缺血：血管外科学会临床实践指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5ac299858ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939381, encodeId=9b2d193938129, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：多西他赛和环磷酰胺辅助治疗HER2阴性乳腺癌的现实经验, objectType=article, longId=728385, objectId=dc7ae283851f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc7ae283851f, replyNumber=0, likeNumber=87, createdTime=2023-04-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc7ae283851f, moduleTitle=2022 ASCO：多西他赛和环磷酰胺辅助治疗HER2阴性乳腺癌的现实经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc7ae283851f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939440, encodeId=8305193944008, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：低骨钙素水平的2型糖尿病患者的死亡风险较高, objectType=article, longId=729228, objectId=cf9fe29228b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf9fe29228b4, replyNumber=0, likeNumber=0, createdTime=2023-01-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf9fe29228b4, moduleTitle=Cardiovasc Diabetol：低骨钙素水平的2型糖尿病患者的死亡风险较高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf9fe29228b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939289, encodeId=ad8419392896e, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：C 肽水平可预测糖尿病患者的心血管疾病风险, objectType=article, longId=292072, objectId=92fa2920e24d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92fa2920e24d, replyNumber=0, likeNumber=90, createdTime=2022-01-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92fa2920e24d, moduleTitle=Cardiovasc Diabetol：C 肽水平可预测糖尿病患者的心血管疾病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92fa2920e24d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939453, encodeId=fafe1939453d1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：与肥胖个体健康相关的生物标志物, objectType=article, longId=731143, objectId=5da4e311432f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5da4e311432f, replyNumber=0, likeNumber=74, createdTime=2023-03-27, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5da4e311432f, moduleTitle=Cardiovasc Diabetol：与肥胖个体健康相关的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5da4e311432f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939449, encodeId=2dbc1939449db, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：糖尿病+心衰患者的进行性右心室功能变化, objectType=article, longId=730368, objectId=f8efe303687d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8efe303687d, replyNumber=0, likeNumber=82, createdTime=2022-12-29, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8efe303687d, moduleTitle=Cardiovasc Diabetol：糖尿病+心衰患者的进行性右心室功能变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8efe303687d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939411, encodeId=ede119394113f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2022速递：中国胶质瘤患者EGFR突变的研究概况, objectType=article, longId=728514, objectId=acbee2851469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acbee2851469, replyNumber=0, likeNumber=101, createdTime=2022-11-04, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acbee2851469, moduleTitle=ASCO2022速递：中国胶质瘤患者EGFR突变的研究概况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acbee2851469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939266, encodeId=3f43193926628, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：比较恩格列净+利格列汀与二甲双胍+甘精胰岛素联合降糖方案对肾脏血流动力学影响的差异, objectType=article, longId=219957, objectId=80bd21995e2d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80bd21995e2d, replyNumber=0, likeNumber=74, createdTime=2022-09-25, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80bd21995e2d, moduleTitle=Cardiovasc Diabetol：比较恩格列净+利格列汀与二甲双胍+甘精胰岛素联合降糖方案对肾脏血流动力学影响的差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80bd21995e2d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO：Denosumab辅助治疗乳腺癌的长期预后

2022-11-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Res：Kcnk3 功能障碍促进左心疾病相关肺动脉高压进展

2022-04-28

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 新辅助化疗对Borrmann Ⅳ型胃癌疗效有限

2022-07-12

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：空腹血糖变异性越高，心血管疾病风险越高！

2022-03-26

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：基于查尔森合并症指数（CCI）预测急性早幼粒细胞白血病（APL）的早期死亡率和总生存期

2022-11-22

quxin068 (审核中...)

前往app查看评论内容

#ASC#

CARDIOVASC DIABETOL：在有心血管高风险因素的糖尿病患者中，运动频率与肾脏、心血管转归的关系如何？

2022-07-22

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：血脂变异性对2型糖尿病患者死亡率的影响

2022-01-10

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | MAINTAIN全新思路：CDK4/6抑制剂失败后跨线再战，瑞博西利仍可带来PFS获益！

2022-11-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！

2023-02-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果

2022-11-07

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：内脏肥胖指数越高，糖尿病肾病风险越高！

2022-06-26

quxin068 (审核中...)

前往app查看评论内容

#ASC#

肿瘤患者治疗期间如何饮食、运动、体重管理？ASCO指南来指导

2022-09-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Journal of Vascular Surgery：重磅｜慢性肠系膜缺血：血管外科学会临床实践指南

2022-11-11

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：多西他赛和环磷酰胺辅助治疗HER2阴性乳腺癌的现实经验

2023-04-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：低骨钙素水平的2型糖尿病患者的死亡风险较高

2023-01-21

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：C 肽水平可预测糖尿病患者的心血管疾病风险

2022-01-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：与肥胖个体健康相关的生物标志物

2023-03-27

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：糖尿病+心衰患者的进行性右心室功能变化

2022-12-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2022速递：中国胶质瘤患者EGFR突变的研究概况

2022-11-04

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：比较恩格列净+利格列汀与二甲双胍+甘精胰岛素联合降糖方案对肾脏血流动力学影响的差异

2022-09-25

科室
- - 订阅+
  - 更多科室
工具
服务